Advanced search
1 file | 321.17 KB Add to list

Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy

(2008) ONCOGENE. 27(30). p.4233-4241
Author
Organization
Abstract
Mutations in the BRCA1-interacting DEAH helicase Brip1 confer an increased risk of breast cancer. In the present study we aimed to unravel the transcriptional control of Brip1 and to determine its expression levels in a set of 101 primary invasive breast carcinomas. Transcription of Brip1 was found to be cell growth-related and controlled by the E2F/retinoblastoma (Rb) pathway through a conserved E2F-responsive site. Repression of Brip1 expression by the cell growth-inhibiting compound 1 alpha,25-dihydroxyvitamin D(3) depended on this same E2F-responsive site. In spite of its role as a tumor suppressor, both quantitative reverse transcriptase-PCR analyses and immunohistochemical stainings showed significantly elevated Brip1 expression levels in grade 3 tumors as compared to grade 1 or 2 carcinomas. Furthermore, increased Brip1 transcript levels were found in tumors with an estrogen receptor-negative, progesterone receptor-negative or HER-2-positive status. In conclusion, these data show that Brip1 is a genuine target gene for the E2F/Rb pathway and that elevated expression levels of Brip1 are detected in primary invasive breast carcinomas with unfavorable characteristics.
Keywords
E2F, high grade, vitamin D, HER-2, FANCONI-ANEMIA, MOLECULAR PORTRAITS, DNA-REPLICATION, HELICASE BRIP1, TARGET GENES, SUSCEPTIBILITY, BACH1, TRANSCRIPTION, CARCINOMAS, MUTATIONS, breast cancer, Brip1

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 321.17 KB

Citation

Please use this url to cite or link to this publication:

MLA
Eelen, G, I Vanden Bempt, L Verlinden, et al. “Expression of the BRCA1-interacting Protein Brip1/BACH1/FANCJ Is Driven by E2F and Correlates with Human Breast Cancer Malignancy.” ONCOGENE 27.30 (2008): 4233–4241. Print.
APA
Eelen, G, Vanden Bempt, I., Verlinden, L., Drijkoningen, M., Smeets, A., Neven, P., Christiaens, M., et al. (2008). Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. ONCOGENE, 27(30), 4233–4241.
Chicago author-date
Eelen, G, I Vanden Bempt, L Verlinden, M Drijkoningen, A Smeets, P Neven, MR Christiaens, Kathleen Marchal, R Bouillon, and A Verstuyf. 2008. “Expression of the BRCA1-interacting Protein Brip1/BACH1/FANCJ Is Driven by E2F and Correlates with Human Breast Cancer Malignancy.” Oncogene 27 (30): 4233–4241.
Chicago author-date (all authors)
Eelen, G, I Vanden Bempt, L Verlinden, M Drijkoningen, A Smeets, P Neven, MR Christiaens, Kathleen Marchal, R Bouillon, and A Verstuyf. 2008. “Expression of the BRCA1-interacting Protein Brip1/BACH1/FANCJ Is Driven by E2F and Correlates with Human Breast Cancer Malignancy.” Oncogene 27 (30): 4233–4241.
Vancouver
1.
Eelen G, Vanden Bempt I, Verlinden L, Drijkoningen M, Smeets A, Neven P, et al. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. ONCOGENE. 2008;27(30):4233–41.
IEEE
[1]
G. Eelen et al., “Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy,” ONCOGENE, vol. 27, no. 30, pp. 4233–4241, 2008.
@article{3186851,
  abstract     = {Mutations in the BRCA1-interacting DEAH helicase Brip1 confer an increased risk of breast cancer. In the present study we aimed to unravel the transcriptional control of Brip1 and to determine its expression levels in a set of 101 primary invasive breast carcinomas. Transcription of Brip1 was found to be cell growth-related and controlled by the E2F/retinoblastoma (Rb) pathway through a conserved E2F-responsive site. Repression of Brip1 expression by the cell growth-inhibiting compound 1 alpha,25-dihydroxyvitamin D(3) depended on this same E2F-responsive site. In spite of its role as a tumor suppressor, both quantitative reverse transcriptase-PCR analyses and immunohistochemical stainings showed significantly elevated Brip1 expression levels in grade 3 tumors as compared to grade 1 or 2 carcinomas. Furthermore, increased Brip1 transcript levels were found in tumors with an estrogen receptor-negative, progesterone receptor-negative or HER-2-positive status. In conclusion, these data show that Brip1 is a genuine target gene for the E2F/Rb pathway and that elevated expression levels of Brip1 are detected in primary invasive breast carcinomas with unfavorable characteristics.},
  author       = {Eelen, G and Vanden Bempt, I and Verlinden, L and Drijkoningen, M and Smeets, A and Neven, P and Christiaens, MR and Marchal, Kathleen and Bouillon, R and Verstuyf, A},
  issn         = {0950-9232},
  journal      = {ONCOGENE},
  keywords     = {E2F,high grade,vitamin D,HER-2,FANCONI-ANEMIA,MOLECULAR PORTRAITS,DNA-REPLICATION,HELICASE BRIP1,TARGET GENES,SUSCEPTIBILITY,BACH1,TRANSCRIPTION,CARCINOMAS,MUTATIONS,breast cancer,Brip1},
  language     = {eng},
  number       = {30},
  pages        = {4233--4241},
  title        = {Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy},
  url          = {http://dx.doi.org/10.1038/onc.2008.51},
  volume       = {27},
  year         = {2008},
}

Altmetric
View in Altmetric
Web of Science
Times cited: